Irinotecan as a maintenance therapy in relapsed Hepatoblastoma-a case report

Irinotecan as a maintenance therapy in relapsed Hepatoblastoma-a case report

Bibliographic Details
Main Authors:	Vimal Kumar, Naresh Shanmugam, Deenadayalan Munirathnam, Priya Ramachandran, Mohamed Rela, Julius Xavier Scott
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124517300281

Similar Items

Irinotecan as a maintenance therapy in relapsed Hepatoblastoma- a case report
by: Dr. Dhanalakshmi, et al.
Published: (2016-01-01)

Multidisciplinary management of hepatoblastoma with incorporation of liver transplantation in children
by: Vimal Kumar, et al.
Published: (2016-01-01)

Outcomes for high‐risk hepatoblastoma in a resource‐challenged setting
by: A. Rammohan, et al.
Published: (2020-08-01)

The extended Kasai portoenterostomy for biliary atresia: A preliminary report
by: Priya Ramachandran, et al.
Published: (2016-01-01)

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
by: Juan Wang, et al.
Published: (2021-09-01)

Hepatoblastoma
by: Raùl Pichardo-Bahena, et al.
Published: (2005-04-01)

Adult hepatoblastoma
by: Javier A. Cienfuegos, et al.

A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory or Relapsed Small Cell Lung Cancer
by: Shufei YU, et al.
Published: (2013-09-01)

Clinicopathological profile of hepatoblastoma: An experience from a tertiary care center in India
by: B Archana, et al.
Published: (2019-01-01)

Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer
by: He XING, et al.
Published: (2021-03-01)

Mendelian susceptibility to mycobacterial disease masquerading as lymphoproliferative disorder
by: Thulasi Raman Ramalingam, et al.
Published: (2020-01-01)

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma
by: Laura L. Stafman, et al.
Published: (2019-02-01)

Hepatoblastomas in Oman : Unveiling success
by: Fatma Rabah, et al.
Published: (2015-02-01)

Hepatoblastomas in Oman: Unveiling success
by: Fatma Rabah, et al.
Published: (2015-01-01)

The Genetic Changes of Hepatoblastoma
by: Huitong Chen, et al.
Published: (2021-07-01)

Hepatoblastoma: when to screen?
by: O’Malley Margaret, et al.
Published: (2011-03-01)

Hepatoblastoma with precocious puberty
by: Enono Yhoshu, et al.
Published: (2019-01-01)

Hemophilia A presenting with quadriparesis, a rare clinical presentation
by: Supriya Gujjar Suresh, et al.
Published: (2016-10-01)

Hepatoblastoma in the neonatal period: An unusual presentation
by: Sarbani Chattopadhyay, et al.
Published: (2012-01-01)

Extrahepatic hepatoblastoma- an extremely rare occurrence
by: Y.K. Sarin, et al.
Published: (2021-04-01)

Adult hepatoblastoma: case report with adrenal recurrence
by: Óscar Caso-Maestro, et al.
Published: (2013-12-01)

A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.
by: Rajkumar Venkatramani, et al.
Published: (2013-01-01)

Prenatal Diagnosis of Congenital Hepatoblastoma
by: Jia-Yan Wang, et al.
Published: (2020-04-01)

Mesenchymal Hamartoma Mimicking Hepatoblastoma
by: A Bahador, et al.
Published: (2014-05-01)

Hepatoblastoma associated with trisomy 18
by: Naruhiko Murase, et al.
Published: (2020-01-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

A case of giant hepatoblastoma
by: MA Linjie, et al.
Published: (2016-11-01)

Diagnóstico prenatal de hepatoblastoma congénito: reporte de un caso Prenatal diagnosis of a congenital hepatoblastoma: a case report
by: Luz Stella Luque, et al.
Published: (2003-03-01)

Weight maintenance and relapse in obesity
by: Byrne, Susan Mary
Published: (2001)

Embryonal/Fetal Subtype Hepatoblastoma: A Case Report
by: I Spyridakis, et al.
Published: (2014-09-01)

Precocious puberty in an infant with hepatoblastoma: a case report
by: Ajlouni Fatenah, et al.
Published: (2011-08-01)

HEPATOBLASTOMA REQUIRING LIVER TRANSPLANTATION. A CASE REPORT
by: Roxana-Cristina Mares, et al.
Published: (2019-03-01)

Irinotecan-Induced Dysarthria
by: Albertine J. Dressel, et al.
Published: (2012-01-01)

Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
by: S V Khokhlova
Published: (2017-09-01)

Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy
by: Eric L. Tam, et al.
Published: (2019-01-01)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
by: Junting Huang, et al.
Published: (2020-11-01)

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas
by: Ida Russo, et al.
Published: (2020-08-01)

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
by: Vadiaka Maria, et al.
Published: (2002-01-01)

CITED1 Expression in Liver Development and Hepatoblastoma
by: Andrew J. Murphy, et al.
Published: (2012-12-01)

Hepatoblastoma survival and the prognostic role of cancer stem cell markers
by: Mohamed Fawzy, et al.
Published: (2014-02-01)

Cannot write session to /tmp/vufind_sessions/sess_qg7cvbb34mn8dakhq9a1ri2u68